← Back to All Filings

Baker Bros. Advisors Reports Routine Quarterly Director Retainer Stock Grant for Incyte Corp

Low SignificanceOctober 2, 2026 at 10:32:41 PM UTC

INCYTE CORP

$INCY4CIK: 0000879169

Subscribe to track INCY

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

{ "title": "INCYTE CORP (INCY) - Form 4 Filing Alert", "color": 3447003, "fields": [ { "name": "Reporting Owner", "value": "Baker Bros. Advisors LP (Director & 10% Owner)", "inline": false }, { "name": "Transaction Type", "value": "Grant (In lieu of Director Retainer Fees)", "inline": true }, { "name": "Shares Acquired", "value": "322", "inline": true }, { "name": "Transaction Price", "value": "$0.00 ($40,500 fee value)", "inline": true }, { "name": "Total Indirect Holdings", "value": "~31M+ shares across affiliated funds", "inline": false } ], "footer": { "text": "Filing Date: 2026-10-02 | Period: 2026-09-30" } }

Comprehensive Analysis

Executive Summary

On October 2, 2026, Baker Bros. Advisors LP and affiliated entities filed a Form 4 disclosing the acquisition of 322 shares of Incyte Corporation (NASDAQ: INCY) common stock on September 30, 2026. The transaction represents a routine equity issuance in lieu of quarterly director retainer fees of $40,500 for Julian C. Baker's board service.

Transaction Details

  • Security: Common Stock
  • Date: September 30, 2026
  • Shares Acquired: 322 shares
  • Transaction Price: $0.00 (issued under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of $40,500 in quarterly director retainer fees)
  • Nature of Ownership: Indirectly held for the benefit of 667, L.P. and Baker Brothers Life Sciences, L.P.

Beneficial Ownership Breakdown

Following this transaction, the reporting entities and principals control substantial indirect and direct positions:

  • Baker Brothers Life Sciences, L.P.: 28,206,082 shares
  • 667, L.P.: 2,835,403 shares
  • Julian C. Baker (Direct): 278,773 shares
  • Felix J. Baker (Direct): 281,190 shares
  • FBB Associates (Indirect): 33,410 shares

Market & Trading Significance

This transaction carries Low informational significance for investors. It represents standard director compensation settled in equity rather than cash, in line with prior quarterly compensation practices, and has negligible impact on the overall multi-million share stake held by Baker Bros. Advisors.

Topics:#Incyte#INCY#InsiderTrading#Biotech#SECForm4

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.